Mark Faulkner

Mark Faulkner is an experienced executive in the pharmaceutical and biotech industries, currently serving as the Executive Director and Head of US Sales and National Accounts at Seqirus since April 2019, focusing on public health protection through influenza prevention. Prior to this role, Faulkner was the Head of Sales and National Accounts at PaxVax, Inc., where the emphasis was on developing innovative vaccines for infectious diseases. Faulkner's extensive background includes positions as National Segment Leader at Novartis Vaccines and Diagnostics, Vice President of Marketing and Business Development at ASD Healthcare, and Director of Marketing at both McKesson and Eli Lilly. Faulkner began his career as a Marketing Manager at AdvancePCS, contributing to corporate marketing and communications. An alumnus of Abilene Christian University, Faulkner holds a Bachelor of Business Administration in Marketing.